Year: 2021
Type: review
Abstract: Frequently underestimated, encephalopathy or delirium are common neurological manifestations associated with sepsis. Brain dysfunction occurs in up to 80% of cases and is directly associated with increased mortality and long-term neurocognitive consequences. Although the central nervous system (CNS) has been classically viewed as an immune-privileged system, neuroinflammation is emerging as a central mechanism of brain dysfunction in sepsis. Microglial cells are major players in this setting. Here, we aimed to discuss the current knowledge on how the brain is affected by peripheral immune activation in sepsis and the role of microglia in these processes. This review focused on the molecular pathways of microglial activity in sepsis, its regulatory mechanisms, and their interaction with other CNS cells, especially with neuronal cells and circuits.
Source: Pharmaceuticals
DOI: 10.3390/ph14050416
Institutions: Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Instituto Nacional de Infectologia Evandro Chagas, Institut Pasteur, Université Paris Sciences et Lettres, UCB Pharma (Belgium), Centre Hospitalier Sainte-Anne, Université Paris Descartes, D’Or Institute for Research and Education, Universidade Iguaçu
Language: English
Subfield: Neurology
Field: Neuroscience
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $1,944
OpenAlex ID: W3158924207
